Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.59USD
21 Sep 2018
Change (% chg)

$0.03 (+4.48%)
Prev Close
$0.56
Open
$0.58
Day's High
$0.59
Day's Low
$0.56
Volume
7,784
Avg. Vol
34,941
52-wk High
$3.34
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.10 0.10 0.10 --
Quarter Ending Feb-18 2 0.00 0.00 0.00 --
Year Ending Feb-18 2 0.00 0.00 0.00 --
Year Ending Mar-19 2 3.39 6.49 0.29 --
Year Ending Mar-20 1 1.28 1.28 1.28 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.16 -0.16 -0.16 --
Quarter Ending Feb-18 1 -0.20 -0.20 -0.20 --
Year Ending Feb-18 2 -0.64 -0.29 -0.98 --
Year Ending Mar-19 2 -0.54 -0.34 -0.73 --
Year Ending Mar-20 1 -0.40 -0.40 -0.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.49 32.71
P/E High - Last 5 Yrs. -- 42.04 47.27
P/E Low - Last 5 Yrs. -- 23.56 24.80
Beta -- 0.90 0.87
Price to Sales (TTM) -- 4.35 6.42
Price to Book (MRQ) -- 3.53 3.91
Price to Tangible Book (MRQ) -- 5.09 5.97
Price to Cash Flow (TTM) -- 22.24 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.69
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.57 -5.70
Payout Ratio(TTM) -- 49.39 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.63 8.45
Sales (TTM) vs TTM 1 Yr. Ago -- 4.62 6.71
Sales - 5 Yr. Growth Rate -- 6.93 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 18.71 25.51
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.60
Capital Spending - 5 Yr. Growth Rate -- 7.80 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.19 2.20
Current Ratio (MRQ) -- 2.93 2.97
LT Debt to Equity (MRQ) -- 8.94 11.21
Total Debt to Equity (MRQ) -- 11.22 14.02
Interest Coverage (TTM) -- 41.23 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.18 54.73
Gross Margin - 5 Yr. Avg. -- 53.33 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.71 15.89
Operating Margin (TTM) -- 13.37 3.72
Operating Margin - 5 Yr. Avg. -- 14.29 11.01
Pre-Tax Margin (TTM) -- 13.76 4.04
Pre-Tax Margin - 5 Yr. Avg. -- 14.60 11.19
Net Profit Margin (TTM) -- 10.38 0.77
Net Profit Margin - 5 Yr. Avg. -- 10.89 7.53
Effective Tax Rate (TTM) -- 20.48 20.44
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 820,576,740 715,149,750
Net Income/Employee (TTM) -- 94,890,309 82,590,366
Receivable Turnover (TTM) -- 5.00 5.01
Inventory Turnover (TTM) -- 2.52 3.61
Asset Turnover (TTM) -- 0.83 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 9.99 9.73
Return on Assets - 5 Yr. Avg. -- 11.38 10.90
Return on Investment (TTM) -- 13.04 12.72
Return on Investment - 5 Yr. Avg. -- 14.69 14.02
Return on Equity (TTM) -- 14.98 14.84
Return on Equity - 5 Yr. Avg. -- 15.89 15.37
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.